About Globus Medical
Ticker
info
GMED
Trading on
info
NYSE
ISIN
info
US3795772082
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
Keith W. Pfeil
Headquarters
info
2560 General Armistead Avenue, Audubon, PA, United States, 19403
Employees
info
5,300
Website
info
globusmedical.com
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Metrics
BasicAdvanced
Market cap
info
$8.44B
P/E ratio
info
24.23
EPS
info
$2.58
Dividend Yield
info
0.00%
Beta
info
1.2
Forward P/E ratio
info
19.53
EBIDTA
info
$735M
Ex dividend date
info
-
Price & volume
Market cap
info
$8.44B
Average daily volume
info
1.4M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
24.23
Forward P/E
info
19.53
PEG ratio
info
1.78
Trailing P/E
info
24.23
Price to sales
info
3.21
Price to book
info
1.97
Earnings
EPS
info
$2.58
EPS estimate (current quarter)
info
$0.75
EPS estimate (next quarter)
info
$0.80
EBITDA
info
$735M
Revenues (TTM)
info
$2.63B
Revenues per share (TTM)
info
$19.30
Technicals
Beta
info
1.2
52-week High
info
$94.93
52-week Low
info
$51.79
50-day moving average
info
$57.35
200-day moving average
info
$72.19
Short ratio
info
2.94
Short %
info
4.76%
Management effectiveness
ROE (TTM)
info
8.62%
ROA (TTM)
info
5.82%
Profit margin
info
13.58%
Gross profit margin
info
$1.76B
Operating margin
info
17.33%
Growth
Quarterly earnings growth (YoY)
info
547.80%
Quarterly revenue growth (YoY)
info
18.40%
Share stats
Outstanding Shares
info
113M
Float
info
112M
Insiders %
info
0.69%
Institutions %
info
104.08%
Analyst Insights & forecasts
info

65% Buy

35% Hold

0% Sell

Based on information from 14 analysts.

Average price target

info
$82.55
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.83
$0.65
27.69%
Q3 • 24Beat
$0.84
$0.75
12.21%
Q4 • 24Beat
$0.68
$0.57
19.30%
Q1 • 25Beat
$0.86
$0.76
13.16%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$598M
$75.5M
12.62%
Q1 • 25
$745M
$203M
27.22%
Q2 • 25
24.61%
168.81%
115.71%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$4.71B
$623M
13.23%
Q1 • 25
$4.96B
$665M
13.41%
Q2 • 25
5.31%
6.79%
1.41%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$177M
$131M
$-635M
$136M
Q1 • 25
$77.9M
$-299M
$-24.9M
$36.3M
Q2 • 25
-56.08%
-327.66%
-96.08%
-73.35%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Globus Medical share?
Collapse

Globus Medical shares are currently traded for undefined per share.

How many shares does Globus Medical have?
Collapse

Globus Medical currently has 113M shares.

Does Globus Medical pay dividends?
Collapse

No, Globus Medical doesn't pay dividends.

What is Globus Medical 52 week high?
Collapse

Globus Medical 52 week high is $94.93.

What is Globus Medical 52 week low?
Collapse

Globus Medical 52 week low is $51.79.

What is the 200-day moving average of Globus Medical?
Collapse

Globus Medical 200-day moving average is $72.19.

Who is Globus Medical CEO?
Collapse

The CEO of Globus Medical is Keith W. Pfeil.

How many employees Globus Medical has?
Collapse

Globus Medical has 5,300 employees.

What is the market cap of Globus Medical?
Collapse

The market cap of Globus Medical is $8.44B.

What is the P/E of Globus Medical?
Collapse

The current P/E of Globus Medical is 24.23.

What is the EPS of Globus Medical?
Collapse

The EPS of Globus Medical is $2.58.

What is the PEG Ratio of Globus Medical?
Collapse

The PEG Ratio of Globus Medical is 1.78.

What do analysts say about Globus Medical?
Collapse

According to the analysts Globus Medical is considered a buy.